GlassScriptPhysician profile
Frank Dang
NPI 1629657978
$1,143.76
in general payments reported to CMS, 2019-2025
17 companies · $958 in 2025
The $958 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $186 · 2025: $958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,143.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $257.52 | 2024-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $177.59 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $160.42 | 2024-2025 | |
| Pfizer INC. | $145.98 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $112.34 | 2025 | Rexulti |
| Exact Sciences Corporation | $47.86 | 2024-2025 | Cologuard Collection Kit |
| Lundbeck LLC | $33.90 | 2025 | Rexulti |
| Dexcom, INC. | $32.78 | 2024-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $29.97 | 2025 | Otezla, Repatha |
| Novartis Pharmaceuticals Corporation | $23.95 | 2025 | |
| Inspire Medical Systems, INC. | $23.78 | 2024 | Inspire |
| Viatris Specialty LLC | $18.27 | 2025 | Yupelri |
| Dynavax Technologies Corporation | $17.28 | 2024 | Heplisav-B |
| Glaxosmithkline, LLC. | $16.24 | 2024 | Trelegy Ellipta |
| Lilly USA, LLC | $16.22 | 2024 | Mounjaro, Zepbound |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $14.84 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.82 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Dang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.